68Ga-PSMA PET/CT and PET/MRI in high-risk prostate cancer patients

被引：5
|
作者：
Sanli, Yasemin [1 ]
Sanli, Oner [3 ]
Simsek, Duygu Has [4 ]
Subramaniam, Rathan M. [1 ,2 ]
机构：
[1] Univ Texas Southwestern Med Ctr Dallas, Dept Radiol, Div Nucl Med, Dallas, TX USA
[2] Univ Texas Southwestern Med Ctr Dallas, Harold C Simmons Comprehens Canc Ctr, Dallas, TX 75390 USA
[3] Istanbul Univ, Istanbul Fac Med, Dept Urol, Istanbul, Turkey
[4] Istanbul Univ, Istanbul Fac Med, Dept Nucl Med, Istanbul, Turkey
来源：
NUCLEAR MEDICINE COMMUNICATIONS | 2018年 / 39卷 / 10期
关键词：
Ga-68-PET; MRI; Ga-68-PSMA PET; CT; high-risk prostate cancer; MEMBRANE ANTIGEN-EXPRESSION; POSITRON-EMISSION-TOMOGRAPHY; ESTRO-SIOG GUIDELINES; RADICAL PROSTATECTOMY; DIAGNOSTIC-ACCURACY; EXTRACAPSULAR EXTENSION; DISEASE RECURRENCE; LYMPH-NODES; WHOLE-BODY; THERAPY;
D O I：
10.1097/MNM.0000000000000888
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
Treatment of high-risk prostate cancer (HRPCa) is challenging. Local staging and metastatic evaluation are important for the patient management. Recently, prostate-specific membrane antigen (PSMA)-based imaging modalities such as PSMA PET/CT and PET/MRI have received significant attention for detection of recurrent prostate cancer sites with elevated prostate-specific antigen levels, after therapy. Current evidence suggests that these imaging modalities may also have a role for the management of patients with HRPCa. In this review, we discuss PSMA-based imaging modalities in the management of patients with HRPCa.
引用
收藏
页码：871 / 880
页数：10
相关论文
共 50 条
  • [31] 68Ga-PSMA PET/CT; current impact on management in prostate cancer
    Intema, F.
    Kooistra, A.
    Lont, A. P.
    Hendriks, L. P. J.
    Esser, J. P.
    Lange, R.
    de Klerk, J. M. H.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S707 - S707
  • [32] Primary staging of prostate cancer using 68Ga-PSMA PET/CT
    Graziani, T.
    Scarlattei, M.
    Baldari, G.
    Migliari, S.
    Sammartano, A.
    Gasparro, D.
    Maestroni, U.
    Ruffini, L.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (SUPPL 1) : S599 - S600
  • [33] Asymptomatic Prostate Cancer Brain Metastases on 68Ga-PSMA PET/CT
    Yin, Charlotte
    Ho, Bao
    Chan, Lyn
    Emmett, Louise
    CLINICAL NUCLEAR MEDICINE, 2019, 44 (06) : E382 - E384
  • [34] 68Ga-PSMA PET/CT in the evaluation of bone metastases in prostate cancer
    Christos Sachpekidis
    P. Bäumer
    K. Kopka
    B. A. Hadaschik
    M. Hohenfellner
    A. Kopp-Schneider
    U. Haberkorn
    A. Dimitrakopoulou-Strauss
    European Journal of Nuclear Medicine and Molecular Imaging, 2018, 45 : 904 - 912
  • [35] 68Ga-PSMA PET/CT in the evaluation of bone metastases in prostate cancer
    Sachpekidis, Christos
    Baeumer, P.
    Kopka, K.
    Hadaschik, B. A.
    Hohenfellner, M.
    Kopp-Schneider, A.
    Haberkorn, U.
    Dimitrakopoulou-Strauss, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 (06) : 904 - 912
  • [36] Diagnostic performance of 68Ga-PSMA PET/CT for restaging prostate cancer
    Hoffmann, Manuela
    Wieler, Helmut
    Maller-Habenthal, Jonas
    Trampert, Ludwin
    Miederer, Matthias
    Schreckenberger, Mathias
    JOURNAL OF NUCLEAR MEDICINE, 2019, 60
  • [37] 68Ga-PSMA and High-Risk Prostate Cancer Staging
    不详
    JOURNAL OF NUCLEAR MEDICINE, 2018, 59 (03) : 19N - 19N
  • [38] Is the 68Ga-PSMA PET-CT the new benchmark for lymphnode staging in high risk prostate cancer patients: A comparative study with MRI?
    Gupta, M.
    Choudhury, P. S.
    Hazarika, D.
    Rawal, S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 : S346 - S346
  • [39] 68Ga-PSMA PET/CT for Primary Lymph Node and Distant Metastasis NM Staging of High-Risk Prostate Cancer
    Klingenberg, Soren
    Jochumsen, Mads R.
    Ulhoi, Benedicte P.
    Fredsoe, Jacob
    Sorensen, Karina D.
    Borre, Michael
    Bouchelouche, Kirsten
    JOURNAL OF NUCLEAR MEDICINE, 2021, 62 (02) : 214 - 220
  • [40] 68Ga-PSMA PET/CT better characterises localised prostate cancer after MRI and transperineal prostate biopsy: Is68Ga-PSMA PET/CT guided biopsy the future?
    Donato, Peter
    Morton, Andrew
    Yaxley, John
    Ranasinghe, Sachinka
    Teloken, Patrick E.
    Kyle, Samuel
    Coughlin, Geoff
    Esler, Rachel
    Dunglison, Nigel
    Gardiner, Robert A.
    Roberts, Matthew J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (08) : 1843 - 1851
12345